Apotheken | Arzt | Interaktionen | Medikamente | MiGeL | Services | Spital | Zulassungsi.
L03AX03 - Bcg VaccineATC-DDD Version 2016. Source: WHO
L - Antineoplastic and Immunomodulating Agents

This group comprises preparations used in the treatment of neoplastic diseases, and immunomodulating agents.
Corticosteroids for systemic use, see H02.

L03 - Immunostimulants

Immunosuppressants, see L04A.

L03A - Immunostimulants

Levamisole, which also affects the immune response, is classified in P02CE.

L03AX - Other Immunostimulants

The DDD for tasonermin is based on single dose treatment.
The DDD of 0.5 mg (P) for histamine dihydrochloride is based on the total dose devided by days of first treatment cycle (42 days).

L03AX03 - Bcg Vaccine
2023 ©ywesee GmbH
Einstellungen | Hilfe | FAQ | Anmeldung | Kontakt | Home